Abstract: While males and combined couple factors play a large part in infertility cases, women often carry the physical, social, and emotional burden of these diagnoses. Nurse practitioners are in a prime position to assess women at risk for infertility, initiate an investigation to identify potential etiologies, refer women to specialized centers, and provide them with ongoing care and support through this diffi cult period in their lives. Helping patients through the pain of infertility factor, another third are due to a male factor, and the remaining third are due to a combination of factors, of which 20% are unexplained.
nfertility is defi ned as the inability to conceive a pregnancy after 1 year of unprotected regular intercourse. 1 Chandra and colleagues reported that infertility affects 7.4% of married women or more than 2 million couples in the United States alone. 2 National estimates of infertility are based upon data from the National Survey of Family Growth (NSFG), which is couple-based and focuses exclusively on married women. Given this definition, it is likely that the current rates of infertility are underestimated, as single women may also be struggling with fertility problems.
Previous cycles from the NSFG have demonstrated increased rates of infertility among Black women. According to recent data, this trend is ongoing with 7% of White women, 7.7% of Hispanic women, and 11.5% of Black women identifi ed as infertile. 2, 3 A number of sociodemographic factors including income, education, access to healthcare, and racial differences in the prevalence of sexually transmitted infections (STIs) and pelvic infl ammatory diseases (PIDs) also contribute to these disparities. 4 
■ Etiology
The American Society for Reproductive Medicine defi nes infertility as a disease and encourages medical evaluation after 12 months of unprotected intercourse that fails to achieve a pregnancy. 5 However, if the female partner is 35 years of age or older, an evaluation is recommended after 6 months of unsuccessful pregnancy attempts. 5 The major causes of infertility can be divided into three basic categories. Approximately one-third of the cases are due to a female By Susan Kelly-Weeder, PhD, FNP-BC PCOS is associated with menstrual irregularities and hyperandrogenism, and characterized by hirsutism, acne, and male pattern alopecia, as well as polycystic ovaries identifi ed on ultrasound. 10 Additional common manifestations of PCOS include obesity, impaired glucose tolerance, and insulin resistan ce. 10 Age-related declines in oocyte quantity and quality have long been associated with the development of infertility in women. Changes in the oocyte have been linked to chromosomal abnormalities and an increase in spontaneous abortion in women over the age of 35. 11 Ovarian function fl uctuates prior to menopause, resulting in irregular menstrual cycles and subsequent fertility impairment. 12 Premature ovarian failure is associated with amenorrhea, estrogen defi ciency, and elevated follicle-stimulating hormone (FSH) prior to the age of 40.
12 Premature ovarian failure has been identifi ed in 1% to 5% of women and is signifi cant in the development of female infertility. 12 Age-related changes in the uterus, such as the development of fi broids and endometrial polyps, also impact a woman's ability to conceive. 11 Tubal factors have been implicated in 30% of female infertility cases. 13 STIs and PIDs are associated with the development of tubal infertility, and chlamydia infections are particularly problematic. Chlamydia is asymptomatic in 75% of women and infections of the lower genital tract are known to ascend, causing intramural infl ammation and tubal scarring. [14] [15] [16] Research has indicated that if untreated, 20% to 40% of women with a previous Chlamydia infection will develop PID, 50% to 70% will develop tubal infertility, and 65% will have an ectopic pregnancy. [17] [18] Additional causes of tubal disease include a previous ectopic pregnancy as well as a history of abdominal or tubal surgery. 13 Endometriosis has also been linked to impaired fertility; however, controversy persists regarding its etiologic role. It has been proposed that endometriosis compromises fertility by causing pelvic adhesions, ovarian and tubal damage, impaired implantation, and endocrine and ovulatory disorders. 19 Early research indicated a higher prevalence of endometriosis in infertile women when compared to their fertile peers; more recent research has not found improvements in fertility following removal of endometrial lesions. 19 Cervical and uterine abnormalities also impact the development of female infertility. Abnormalities of the cervix, cervical mucus production, and sperm/mucus interaction may be involved but are rarely the only cause of an infertility problem. 7 It has been estimated that uterine fi broids or myomas are associated with infertility in 2% to 3% of cases. 20 Researchers suspect that fi broids impair fertility by altering the uterine contour consequently interfering with implantation, sperm movement, and sperm transport. 20 In addition to delaying childbirth, a number of lifestyle choices affect the development of infertility issues. [21] [22] Tobacco use and its association with fertility impairment has been well studied and the deleterious effects are well documented. 23 Cigarette smoking by women has been linked to conception delay, ovarian follicular depletion, chromosomal damage, an increase in miscarriage, as well as reduced success from assisted reproductive technologies (ARTs). 23 Male fertility is also impacted by exposure to tobacco as researchers have demonstrated reductions in sperm quality in smokers. 23 Caffeine and alcohol use have also been implicated in the development of female infertility. However, the researchers investigating these associations have not found conclusive evidence to link these behaviors with infertility. 24 Weight is another contributing factor in the development of infertility. Overweight and obese women are at increased risk for anovulation, menstrual irregularities, reduced conception rates, and a decreased response to fertility treatments. [25] [26] To further support this association reductions in body weight, especially reduction in abdominal obesity, have been linked to improved outcomes. 25 There is increasing evidence that obesity in men can also negatively affect fertility. 26 The processes are not fully understood, but researchers have postulated that genetic, thermal, and endocrine mechanisms are involved. than 20. 28 In a recent study of infertile women undergoing fertility treatment, greater than 20% of the women met the criteria for a past or current eating disorder, which exceeds the U.S. average lifetime prevalence of eating disorders. 29 A number of occupational and environmental exposures have also been connected to the development of infertility, and an extensive literature base regarding these exposures has been accumulating. [30] [31] Although a number of compounds have been implicated, inconsistencies have been noted. To date, the strongest evidence available suggests that exposures to heavy metals, especially lead, may be problematic for childbearing-aged women. 30 
Male causes
Male factor infertility is primarily related to sperm abnormalities and any condition that predisposes the male partner to impaired sperm quality or quantity can lead to infertility. 13 Testicular dysfunction is the most common problem and can be due to androgen insensitivity, orchitis, cryptorchidism, congenital or developmental testicular disorder (Klinefelter syndrome), testicular trauma, radiation, systemic disorder, or a Y chromosome defect. 32 Male factor infertility has also been linked to altered sperm transport due to an absent or obstructed vas deferens or epididymis, erectile dysfunction, or retrograde ejaculation. 32 A third category includes problems with hypothalamic-pituitary axis and can be due to a state of androgen or estrogen excess (a tumor), a pituitary adenoma, or a multisystem genetic disorder such as Prader-Willi syndrome. 32 
■ Assessment and evaluation
The extent of the clinical investigation for women with diffi culty in conceiving is dependent upon the practice setting and parameters or guidelines in place for initial workup, testing, and referral. For example, in a family practice setting, the nurse practitioner (NP) may initiate the investigation into possible etiologies for both the male and female partners and refer for defi nitive treatment once a diagnosis is determined. However, in a women's health site, where many women receive both primary and gynecologic care, the NP may begin the investigation and treatment protocols independently or in collaboration with a fertility consultant, while the male partner is referred to a urologist or other specialist.
Regardless of the practice site, both male and female partners need to be evaluated simultaneously and many of the preliminary steps in the infertility investigation can be initiated by the NP caring for the woman and/or infertile couple. Following the history and physical exam, a semen analysis is required. Typically, a minimum of two semen samples, separated by a 1 month period, are obtained before conclusions can be drawn regarding sperm quality or quantity. 32 Further evaluation of the male partner may include an endocrine evaluation if the semen analysis is abnormal or other clinical fi ndings suggest an endocrine disorder. 33 Additional tests may also include postejaculation urinalysis if retrograde ejaculation is suspected, as well as ultrasounds and specialized semen analyses. 32 Preliminary investigation of the female partner should focus on the most likely causes of fertility impairment identifi ed in the history and physical exam. Evaluation of ovulatory function can be assessed by a variety of methods including basal body temperature (BBT) recordings, serum progesterone levels, and urinary luteinizing hormone (LH) detection. 7 BBTs are an inexpensive way to evaluate menstrual cycle changes associated with ovulation. Women are instructed to obtain their basal temperature upon waking every morning. Ovulatory cycles generally reveal a biphasic pattern with a slight elevation in basal temperature (97° F [36.1°C] to 98° F [36.7°C] or higher) associated with progression from the follicular phase to the luteal phase of the cycle. 13 The temperature elevation is noted approximately 2 days after the increase in LH has occurred. 13 Commercial ovulation predictor kits have become popular and have all but replaced BBT in documenting ovulation. 13 These products identify the LH surge in urine 14 to 48 hours prior to ovulation and can be helpful to couples trying to identify the most advantageous timing for intercourse. Results of these tests generally correlate with peak serum LH levels. 7 Serum progesterone levels (greater than 3.0 ng/mL) obtained during the luteal phase, generally measured at the midpoint between ovulation and the end of the cycle, can also provide evidence of ovulation. In women with inadequate ovulatory function, investigation of potential underlying causes is indicated including obtaining a prolactin level and thyroid stimulating hormone (TSH). 7 Women over the age of 35 should have an evaluation of their ovarian reserve which can be done by checking an FSH and estradiol level on day 3 of the menstrual cycle. 11 Favorable results are indicated by an FSH less than 10 mIU/mL and an estradiol level of less than 80 pg/mL. 11 Ovarian reserve can also be evaluated with a clomiphene citrate challenge test, a transvaginal ultrasound to obtain an antral follicle count, or an endometrial biopsy. 11, 13 A clomiphene challenge test consists of measuring FSH on day 3 of the cycle followed by the administration of clomiphene citrate for days 5 to 9 and then a repeat FSH on day 10. 11 The test is abnormal if either the day 3 or day 10 FSH is above the accepted reference range established by the lab. 11 Women over 40 who report amenorrhea may be experiencing ovarian failure, which can be determined by an elevated FSH. 11, 13 Tubal causes of infertility are common and need to be evaluated. A hysterosalpingogram is the traditional method used to evaluate the fallopian tubes for patency. 7 In addition to the information on tubal patency, this imaging exam, conducted with a water-or lipid-soluble contrast media, can provide information on the contour of the uterine cavity. 7, 13 An ultrasound and/or laparoscopy may be utilized to further evaluate uterine and pelvic pathology including the presence of endometriosis, endometriomas, or fi broid tumors. 7 Cervical factors impacting fertility can be evaluated during the pelvic exam. The postcoital test, once a mainstay of the infertility investigation, has been eliminated from the workup of infertile women. 7 This procedure focused on examining the cervical mucus and identifying evidence of motile sperm in the vaginal vault following intercourse. Controversy has surrounded this procedure due to inconsistencies in technique, timing, and interpretation of the results. 7 ■ Management Management of female infertility should be individualized and focused on the fi ndings obtained from the clinical investigation of potential etiologies. The role of the NP in the management of the infertile woman or couple is again likely to be practice-site specifi c. In a woman's health site, the NP may initiate a number of different treatment protocols; however, in other sites, the NP role at this juncture may be to refer to an infertility specialist or an in-vitro fertilization (IVF)/ART specialized site.
Regardless of the practice site, all infertile women and couples should receive counseling and education regarding optimal intercourse frequency and scheduling. Instructions should be given indicating that conception is most likely to occur in the 3 days prior to ovulation and that every other day coital frequency is recommended. 33, 34 Women should also be advised to avoid douching and using lubricants during intercourse as these may interfere with conception.
potential risk factors. Women should be advised to decrease or stop smoking and reduce or eliminate caffeine and alcohol use. Additionally, women who are overweight or obese should be advised to lose weight and referred to a weight reduction program. Underweight women should be assessed for their eating and exercise habits and, if an eating disorder is suspected, appropriate referral should be initiated.
The NP should also allow time for the woman to express her concerns and feelings regarding the evaluation and treatment of her fertility-related problem. Infertility diagnoses and treatments can cause increased stress for the woman or the couple, so information on available support groups should be provided as well. RESOLVE: The National Infertility Association is a nonprofi t organization devoted to the care and support of infertile couples and offers a wide range of information, resources, and support (http://www. resolve.org/).
■ Treatment options
Ovulatory problems are the most commonly noted etiologies of infertility in women and are the most amenable to treatment. 1 Women with an underlying cause of ovulatory dysfunction (such as thyroid disease) should have treatment directed at these causes. For women with an elevated prolactin level, dopamine receptor agonist medications such as bromocriptine (Parlodel) may be successful in restoring normal ovulatory cycles. 36 Women with PCOS have benefi ted from the administration of metformin with an increase in ovulation and conception rates noted. 10, 12, 37 For women without an obvious underlying etiology, improved rates of ovulatory cycles have been noted in response to an ovulation-stimulating agent such as clomiphene citrate (Clomid) or human menopausal gonadotropins (Pergonal). 12 The major adverse reactions of these medications include ovarian hyperstimulation syndrome and multiple gestations. 14 For women with limited ovarian reserve, oocyte donation has shown the greatest success. 12 Surgical options are available for women with tubal infertility and uterine and pelvic abnormalities including fi broid tumors and endometriosis. 7 However, tubal surgery is rarely successful and can be associated with the development of subsequent ectopic pregnancies. 38 Women with these problems often benefi t from ovulation induction with or without intrauterine insemination (IUI) as well as advanced procedures including IVF/ART. 38 Varicocele repair has been shown to improve semen quality in men; however, it has not been shown to increase success with conception. 39 Abnormalities identifi ed in semen analysis should be referred to an infertility specialist and couples with these problems typically benefi t from IUI and IVF procedures. 13, 32 IVF and ART In-vitro fertilization (IVF) is a method of assisted reproduction that involves combining oocyte and sperm cells in a lab setting and then transferring the resulting embryo into the uterus. 6 Because this process bypasses the fallopian tubes, IVF is often the treatment of choice for women with tubal disease, as well as those with unexplained infertility. 39 IVF procedures are expensive and are not covered by medical insurance in many states. 6 This requires couples to pay "out of pocket" and therefore, these procedures become inaccessible. 41, 42 While IVF/ART procedures can be benefi cial, the most current data indicates that only 35.4% of cycles result in a clinical pregnancy and 29% result in a live birth. 43 While this does refl ect signifi cant progress for infertile couples, the vast majority of IVF/ART cycles (63.9%) still do not result in clinical pregnancies. 43 
■ Complementary and alternative methods
A variety of complementary and alternative treatments are reported to improve fertility in women. It has been suggested that the use of botanicals with antioxidant properties, particularly vitamins A, C, and E may reduce oxidative stress associated with infertility; however, there have been few clinical trials investigating this phenomenon. 44, 45 Relaxation techniques have also been studied in groups of infertile women. In an often cited study by Barbieri and associates,110 infertile women were placed in three different treatment options: an infertility support group, a relaxation group that included yoga and meditation exercises, and a control group which only received fertility medications. 46 One year later, approximately 50% of the women in the support and relaxation groups had become pregnant, compared to only 20% of the women in the medication-only group. 46 Acupuncture and its role in improving female fertility has also been widely studied. Acupuncture has been postulated to improve ovarian and uterine blood flow through the ovarian sympathetic nerves via the supraspinal pathways. 47 The presumption is that if acupuncture can improve uterine blood fl ow, it can also improve the endometrial environment for embryo implantation. 47 Acupuncture has been noted to improve relaxation in women undergoing fertility treatment. Specifically, 86% women reported increased feelings of relaxation following acupuncture treatments. 47 
■ Conclusion
As primary care providers, NPs will encounter numerous women who are struggling with their fertility. By utilizing thorough assessment techniques, focused diagnostic procedures, and appropriate referrals, NPs can provide women with the resources they need to make decisions regarding
